文献速递炎症性肠病

宿主山梨醇与细菌山梨醇利用促进炎症性肠病中的艰难梭菌感染

Host Sorbitol and Bacterial Sorbitol Utilization Promote Clostridioides difficile Infection in Inflammatory Bowel Disease.
PubMed 文献 · Gastroenterology · 2023-03-08

该研究通过回顾性单中心与前瞻性多中心分析及小鼠模型,发现炎症性肠病(IBD)患者艰难梭菌感染(CDI)中ST54丰度增加,ST54携带山梨醇代谢位点并能代谢山梨醇,其致病依赖肠道炎症诱导的条件和山梨醇存在;活动期IBD患者粪便山梨醇浓度显著高于缓解期或健康对照。

要点

  • IBD患者CDI中特定序列型ST54丰度增加,ST54携带山梨醇代谢位点。
  • ST54可在体外和体内代谢山梨醇,其致病依赖肠道炎症和山梨醇。
  • 活动期IBD患者粪便山梨醇浓度显著高于缓解期或健康对照。

核心结论

  • 山梨醇及感染艰难梭菌菌株的山梨醇利用在IBD患者CDI的发病和流行病学中起主要作用。
  • IBD患者CDI可能通过消除饮食山梨醇或抑制宿主来源的山梨醇产生来避免或改善。

研究设计与样本

  • 回顾性单中心与前瞻性多中心分析IBD患者CDI,包括艰难梭菌分离株基因分型。
  • CDI小鼠模型分析山梨醇代谢位点的作用。
  • 分析IBD患者与健康个体粪便中山梨醇浓度。

主要发现

  • 特定谱系与IBD显著相关,尤其是ST54丰度增加。
  • ST54携带山梨醇代谢位点,能在体外和体内代谢山梨醇,而临床主要流行的ST81则不然。
  • 小鼠模型中ST54致病依赖肠道炎症诱导的条件和山梨醇存在。
  • 活动期IBD患者粪便山梨醇浓度显著高于缓解期患者或健康对照。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Inflammatory bowel disease (IBD) is a widespread gastrointestinal inflammatory disorder with globally increasing incidence. Clostridioides difficile infection (CDI) often occurs in patients with intestinal dysbiosis, such as after antibiotic therapy. Patients with IBD have increased incidence of CDI and the clinical outcome of IBD is reportedly worsened by CDI. However, the underlying reasons remain poorly understood. METHODS: We performed a retrospective single-center and a prospective multicenter analysis of CDI in patients with IBD, including genetic typing of C difficile isolates. Furthermore, we performed a CDI mouse model to analyze the role of the sorbitol metabolization locus that we found distinguished the main IBD- and non-IBD-associated sequence types (STs). Moreover, we analyzed sorbitol concentration in the feces of patients with IBD and healthy individuals. RESULTS: We detected a significant association of specific lineages with IBD, particularly increased abundance of ST54. We found that in contrast to the otherwise clinically predominant ST81, ST54 harbors a sorbitol metabolization locus and was able to metabolize sorbitol in vitro and in vivo. Notably, in the mouse model, ST54 pathogenesis was dependent on intestinal inflammation-induced conditions and the presence of sorbitol. Furthermore, we detected significantly increased sorbitol concentrations in the feces of patients with active IBD vs patients in remission or healthy controls. CONCLUSIONS: Sorbitol and sorbitol utilization in the infecting C difficile strain play major roles for the pathogenesis and epidemiology of CDI in patients with IBD. CDI in patients with IBD may thus be avoided or improved by elimination of dietary sorbitol or suppression of host-derived sorbitol production.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Yang Z, Qin J, Zhao L, et al. Host Sorbitol and Bacterial Sorbitol Utilization Promote Clostridioides difficile Infection in Inflammatory Bowel Disease. Gastroenterology. 2023. PMID: 36898551. doi:10.1053/j.gastro.2023.02.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。